| Literature DB >> 16548834 |
Sharon Van Doornum1, Garry L R Jennings, Ian P Wicks.
Abstract
Rheumatoid arthritis is associated with an increase in cardiovascular mortality and morbidity; this increase is independent of traditional cardiovascular risk factors. Effective treatment of rheumatoid arthritis with disease-modifying antirheumatic drugs appears to reduce cardiovascular mortality. The optimal approach to prevention of cardiovascular disease in rheumatoid arthritis is evolving, but will include a combination of: cardiovascular risk factor screening and management; effective and sustained control of joint and systemic inflammation; and a high index of suspicion for silent cardiac disease.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16548834 DOI： 10.5694/j.1326-5377.2006.tb00239.x
Source DB: PubMed Journal: Med J Aust ISSN： 0025-729X Impact factor: 7.738